SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is experiencing a sharp sell-off as investors react to back-to-back adverse court rulings regarding the platform's impact on young users, fueling fears that these cases could set a precedent for thousands of future lawsuits. The community is deeply polarized, with some bulls viewing the dip as an overreaction and a buying opportunity, while others are panic-selling, citing concerns over long-term legal liabilities, heavy AI spending, and broader market instability.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as the community highlights its strategic role in bridging traditional finance and blockchain, particularly through its high-profile partnership with Franklin Templeton to tokenize ETFs. Investors remain highly focused on its long-term potential as a leader in real-world assets, though discussions reflect ongoing tension between the project's institutional momentum and concerns over token dilution from upcoming supply unlocks.

Robinhood Ventures Fund I invest in companies located in the United States. The fund focuses on a broad range of sectors and industries. It provides financing for early stage transactions.

Robinhood Ventures Fund I - Common shares of beneficial interest

The community is actively discussing the Robinhood Ventures Fund I, with many participants speculating on its potential to replicate the rapid growth seen in similar venture funds. Traders are closely monitoring the fund's current holdings and the potential for future high-profile acquisitions to drive significant price appreciation, despite concerns regarding the fund's expense ratio and the transparency of its valuation.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is capturing market attention as institutional investors and the community closely track its progress in the CAR-T autoimmune space, specifically regarding the upcoming BLA submission and Phase 3 registrational trials for miv-cel. Discussion is fueled by strong insider confidence, robust institutional ownership, and anticipation of data readouts from its pipeline targeting conditions like Stiff Person Syndrome and Myasthenia Gravis.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as shares surge on the back of positive Phase 3 clinical trial results for its Zenkuda eye treatment. The community is actively debating the stock's potential for further upside against the risk of future capital raises and the company's past volatility.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival Corp is facing significant volatility as investors weigh the impact of rising oil prices and geopolitical tensions in the Middle East on cruise operations. While the community is actively debating the stock's sensitivity to fuel costs and broader travel sentiment, many shareholders argue that current share price weakness is an overreaction given the company's strong bookings, record occupancy, and limited direct exposure to the conflict region.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid high-stakes volatility as market participants react to shifting signals regarding U.S. military posture in the Middle East and the company's internal fiscal performance. Community discourse is heavily polarized, with critics pointing to mounting losses and geopolitical instability, while supporters maintain a focus on the platform's role in the broader media landscape and political developments.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop is trending as investors weigh its robust growth and global expansion plans against concerns over its premium valuation and recent performance shifts in the fast-casual sector. The community is actively debating the sustainability of its store count growth and the impact of its share repurchase programs amidst a broader, often volatile, consumer discretionary environment.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

SQQQ is trending as investors aggressively hedge against market volatility driven by Middle East geopolitical tensions and concerns over potential inflation. Traders are actively debating the sustainability of the current market rally, with many utilizing the inverse fund to hedge their portfolios as they monitor key technical levels and signals of a broader market correction.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as investors weigh the impact of the company's decision to delist from the TSX to focus exclusively on Nasdaq, a move aimed at streamlining trading and improving institutional liquidity. While some in the community see the delisting as a bullish step to reduce arbitrage pressure, sentiment remains deeply polarized as shareholders actively debate the lack of official updates regarding the Helios data center and the potential for a business split to unlock value.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Moore Capital Management LP Acquires Shares of 55,000 Bio-Rad Laboratories, Inc. $BIO

Moore Capital Management LP bought a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to the company in its most recent filing with the...

Gotham Asset Management LLC Acquires 36,763 Shares of Bio-Rad Laboratories, Inc. $BIO

Gotham Asset Management LLC boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 41.8% during the 3rd quarter, according to its most recent disclosure with the Securities...

Hound Partners LLC Has $29.15 Million Stake in Bio-Rad Laboratories, Inc. $BIO

Hound Partners LLC decreased its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 42.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The...

Bio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Hold" by Brokerages

Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has been given a consensus rating of "Hold" by the six research firms that are covering the stock, Marketbeat Ratings reports. One research...

Mangrove Partners IM LLC Invests $35.57 Million in Bio-Rad Laboratories, Inc. $BIO

Mangrove Partners IM LLC acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to its most recent 13F filing with the Securities...

Perbak Capital Partners LLP Purchases 5,423 Shares of Bio-Rad Laboratories, Inc. $BIO

Perbak Capital Partners LLP grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 171.7% in the third quarter, according to the company in its most recent 13F filing...

Portolan Capital Management LLC Has $13.02 Million Stock Position in Bio-Rad Laboratories, Inc. $BIO

Portolan Capital Management LLC reduced its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.0% during the 3rd quarter, according to the company in its most recent disclosure...

10,425 Shares in Bio-Rad Laboratories, Inc. $BIO Purchased by Magnetar Financial LLC

Magnetar Financial LLC acquired a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC...

Bio-Rad Laboratories, Inc. $BIO Shares Purchased by Natixis Advisors LLC

Natixis Advisors LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 67.1% during the 3rd quarter, according to the company in its most recent filing with the...

Capital Research Global Investors Makes New Investment in Bio-Rad Laboratories, Inc. $BIO

Capital Research Global Investors bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to the company in its most recent filing...

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$1.84	--	--	N/A
Q4 '25	$2.71	$2.51	-7.31%	MISSED
Q3 '25	$1.95	$2.26	15.66%	BEAT
Q2 '25	$1.73	$2.61	50.52%	BEAT
Q1 '25	$1.81	$2.54	40.31%	BEAT

BIO
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest BIO News

BIOBio-Rad Laboratories Inc. - Ordinary Shares - Class A